Literature DB >> 6461714

Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. I. Alloreactive suppressor cells rather than killer T cells appear to be the decisive effector cells in lethal graft-vs.-host disease.

A G Rolink, T Radaszkiewicz, S T Pals, W G van der Meer, E Gleichmann.   

Abstract

Splenic T cells from B10 donors were injected into irradiated (B10 x DBA/2)F1 mice. Either 5 or 6 d later, activated donor T cells were recovered from the spleens of these primary F1 (1 degree F1) recipients and transferred to groups of nonirradiated syngeneic F1 (2 degrees F1) recipients. Whereas day-5-activated parental T cells induced the characteristic symptoms of acute graft-vs.-host disease (GVHD) and eventually lethal GVHD, day-6-activated B10 T cells failed to induce acute GVHD but induced symptoms of chronic GVHD. Interestingly, the inability of day-6-activated T cells to induce lethal GVHD could not be ascribed to a lack in anti-F1 T killer cells. The combined results of functional studies indicated that day-6 cells were enriched for alloreactive helper T cells, whereas day-5 cells were enriched for alloreactive suppressor cells. Hence, our findings indicate that acute GVHD and lethal GVHD are caused by alloreactive donor T suppressor but not T killer cells, and that symptoms of chronic GVHD are caused by alloreactive donor T helper cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6461714      PMCID: PMC2186671          DOI: 10.1084/jem.155.5.1501

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

2.  Studies of thoracic duct lymphocytes of mice. II. A quantitative comparison of the capacity of thoracic duct lymphocytes and other lymphoid cells to induce graft-versus-host reactions.

Authors:  H Cantor; M A Mandel; R Asofsky
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

3.  Hemopoietic cell-defined components of the major histocompatibility complex of mice: identification of responsive and unresponsive recipients for bone marrow transplants.

Authors:  G Cudkowicz; E Lotzová
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

4.  Interaction of thymus lymphocytes with histoincompatible cells. II. Recirculating lymphocytes derived from antigen-activated thymus cells.

Authors:  J Sprent; J F Miller
Journal:  Cell Immunol       Date:  1972-03       Impact factor: 4.868

5.  Subsets of T cells in the rat mediating lethal graft versus-host disease.

Authors:  D W Mason
Journal:  Transplantation       Date:  1981-09       Impact factor: 4.939

6.  Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora.

Authors:  D W van Bekkum; J Roodenburg; P J Heidt; D van der Waaij
Journal:  J Natl Cancer Inst       Date:  1974-02       Impact factor: 13.506

Review 7.  Cellular immunology and the pathogenesis of graft versus host reactions.

Authors:  W L Elkins
Journal:  Prog Allergy       Date:  1971

8.  Cytokinetics of bone marrow stroma cells after stimulation by partial depletion of the medullary cavity.

Authors:  K Meyer-Hamme; R J Haas; T M Fliedner
Journal:  Acta Haematol       Date:  1971       Impact factor: 2.195

9.  The property of "strength" of histocompatibility antigens, and their ability to produce antigenic competition.

Authors:  W Lawrence; M Simonsen
Journal:  Transplantation       Date:  1967-09-05       Impact factor: 4.939

10.  Studies on immunological paralysis. IX. The immunogenicity and tolerogenicity of levan (polyfructose) in mice.

Authors:  J J Miranda
Journal:  Immunology       Date:  1972-12       Impact factor: 7.397

View more
  18 in total

1.  Graft-versus-host-disease-associated donor cell engraftment in an F1 hybrid model is dependent upon the Fas pathway.

Authors:  T Iwasaki; T Hamano; K Saheki; T Kuroiwa; Y Kataoka; Y Takemoto; A Ogata; J Fujimoto; E Kakishita
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Experimental studies of immunologically mediated enteropathy. V. Destructive enteropathy during an acute graft-versus-host reaction in adult BDF1 mice.

Authors:  A M Mowat; M V Felstein
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

3.  Clonal analysis of the T lymphocytes involved in parent versus F1 graft-versus-host reaction.

Authors:  P F Piguet
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

4.  Immunosuppressive activity of macrophages in mice undergoing graft-versus-host reaction due to major histocompatibility complex class I plus II difference.

Authors:  Y Ikarashi; K Kawai; H Watanabe; Y Matsumoto; S Omata; M Fujiwara
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

5.  Autoimmune disease and malignant lymphoma associated with host-versus-graft disease in mice.

Authors:  M Tateno; N Kondo; T Itoh; T Yoshiki
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

6.  The influence of CD4 T-cell subsets on control of CD4 T-cell-mediated graft-versus-host disease.

Authors:  Halima Moncrieffe; Mark Coles; Brigitta Stockinger
Journal:  Immunology       Date:  2008-05-20       Impact factor: 7.397

7.  Depletion of asialo-GM1+ cells from the F1 recipient mice prior to irradiation and transfusion of parental spleen cells prevents mortality to acute graft-versus-host disease and induction of anti-host specific cytotoxic T cells.

Authors:  K Varkila
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

8.  Gut injury in mouse graft-versus-host reaction. Study of its occurrence and mechanisms.

Authors:  D Guy-Grand; P Vassalli
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

9.  Differential role of all-trans retinoic acid in promoting the development of CD4+ and CD8+ regulatory T cells.

Authors:  Jilin Ma; Ya Liu; Yang Li; Jian Gu; Justin Liu; Jiayou Tang; Julie Wang; Bernhard Ryffel; Yi Shen; David Brand; Zhongmin Liu; Song Guo Zheng
Journal:  J Leukoc Biol       Date:  2013-09-30       Impact factor: 4.962

10.  Insulitis as a consequence of immune dysregulation: further evidence.

Authors:  K Flohr; U Kiesel; G Freytag; H Kolb
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.